Genogrouping and incidence of virulence factors of Enterococcus faecalis in liver transplant patients differ from blood culture and fecal isolates

The Journal of Infectious Diseases
Karola WaarJohn E Degener

Abstract

Enterococcus faecalis is a leading cause of infections in liver transplant patients. This study reviewed the incidence of virulence factors such as hemolysin, gelatinase, aggregation substances (asa1 and asa373), or the enterococcal surface protein (Esp) in isolates from liver transplant patients. In total, 133 isolates from liver transplant patients were compared with 47 isolates from feces of healthy volunteers and 66 isolates from blood cultures. Amplified fragment length polymorphism (AFLP) analysis indicates that the isolates from different clinical subgroups can be divided into genogroups with an AFLP similarity of >80% and different virulence factors. Hemolysin and asa1 might be associated with infection, as they are more frequent in isolates from blood cultures and transplant patients. Esp might be associated with colonization and spread, because it is more frequent in isolates from feces of healthy volunteers and transplant patients. An epidemic esp gene-positive strain among liver transplant patients supports this hypothesis.

Citations

Sep 4, 2007·Applied and Environmental Microbiology·Ekaterina ParamonovaPrashant K Sharma
Jan 18, 2005·Clinical Microbiology Reviews·Gunnar LindahlThomas Areschoug
Dec 8, 2004·Journal of Clinical Microbiology·S M HarringtonW G Merz
Jul 6, 2007·PloS One·Shonna M McBrideMichael S Gilmore
Dec 7, 2007·Diagnostic Microbiology and Infectious Disease·Hervé DupontJean-Marie Desmonts
Feb 16, 2007·Diagnostic Microbiology and Infectious Disease·Andrea MarraThomas D Gootz
Sep 16, 2005·Letters in Applied Microbiology·H LempiäinenA von Wright
Dec 23, 2004·Oral Microbiology and Immunology·C M SedgleyG Dahlén
Oct 12, 2005·International Journal of Food Microbiology·M R Foulquié MorenoL De Vuyst
Dec 1, 2015·Polish Journal of Veterinary Sciences·A KandričákováV Strompfová
Mar 4, 2006·Microbiology·Annet E J van MerodeBastiaan P Krom
Dec 10, 2003·Journal of Medical Microbiology·Roberta CretiLucilla Baldassarri
Dec 15, 2005·The International Journal of Artificial Organs·L BaldassarriC R Arciola
Oct 17, 2008·The International Journal of Artificial Organs·R CretiC R Arciola
May 18, 2006·The International Journal of Artificial Organs·L BaldassarriC R Arciola
May 1, 2018·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·Ali JahansepasMohammad Aghazadeh
Oct 17, 2007·Environmental Science & Technology·Richard L WhitmanMuruleedhara N Byappanahalli

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Related Papers

European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology
H A ElsnerR Wirth
© 2022 Meta ULC. All rights reserved